Kwasi Ansere Ofori, MBChB, MPH
Postdoctoral AssociateAbout
Research
Publications
2026
Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma
Bader J, Dhiman A, Aguirre N, Ofori K, Gupta P, Qin H, Sharma A, Mitchell O, Tjota M, Husain A, Drazer M, Churpek J, Kindler H, Turaga K. Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma. Npj Precision Oncology 2026, 10: 281. PMID: 42426379, PMCID: PMC13373184, DOI: 10.1038/s41698-026-01495-x.Peer-Reviewed Original ResearchThis study investigates the prognostic impact of somatic mutations in mesothelioma, showing NF2 truncating variants worsen survival, supporting genomic testing to guide treatment strategies.ASO Author Reflections: Biological Limitations of ctDNA Surveillance in Colon Cancer: The Peritoneal Conundrum
Ofori K, Turaga K. ASO Author Reflections: Biological Limitations of ctDNA Surveillance in Colon Cancer: The Peritoneal Conundrum. Annals Of Surgical Oncology 2026, 33: 8561-8562. PMID: 42362879, DOI: 10.1245/s10434-026-20076-7.Peer-Reviewed Original ResearchASO Visual Abstract: Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance
Ofori K, Smart H, Liu S, Bader J, Aguirre N, Gupta P, Sharma A, Turaga K. ASO Visual Abstract: Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance. Annals Of Surgical Oncology 2026, 33: 8567-8567. PMID: 42334717, DOI: 10.1245/s10434-026-19980-9.Peer-Reviewed Original ResearchPeritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance
Ofori K, Smart H, Liu S, Bader J, Aguirre N, Gupta P, Sharma A, Turaga K. Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance. Annals Of Surgical Oncology 2026, 33: 8555-8558. PMID: 42265516, DOI: 10.1245/s10434-026-19903-8.Peer-Reviewed Original ResearchThis study investigates the limitations of circulating tumor DNA (ctDNA) surveillance in stage II–III colon cancer, showing reduced detection of isolated peritoneal metastases due to biological constraints.Clinical, Physiologic, and Anatomic Outcomes of a Novel Bioprosthetic Aortic Valved Conduit
Dankwa S, Erez E, Higaki A, Verma S, Hameed I, Talapaneni S, Wang K, Asmelash S, Oden Shobayo T, Khosla P, Ofori K, Assi R, Vallabhajosyula P. Clinical, Physiologic, and Anatomic Outcomes of a Novel Bioprosthetic Aortic Valved Conduit. Journal Of Clinical Medicine 2026, 15: 3437. PMID: 42123170, PMCID: PMC13163905, DOI: 10.3390/jcm15093437.Peer-Reviewed Original ResearchEvolving therapeutics in colorectal cancer peritoneal metastases
Bader J, Aguirre N, Schultz K, Ofori K, Godfrey E, Gupta P, Tseng R, Cecchini M, Sundar R, Turaga K. Evolving therapeutics in colorectal cancer peritoneal metastases. Cancer And Metastasis Reviews 2026, 45: 25. PMID: 42024175, DOI: 10.1007/s10555-026-10335-0.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsNational Trends and Disparities in Mortality From Early-Onset Pancreatic Cancer in the United States, 1999 to 2020.
Orhin A, Akoto N, Mensah B, Naeem A, Ofori K, Burke O, Yeboah E. National Trends and Disparities in Mortality From Early-Onset Pancreatic Cancer in the United States, 1999 to 2020. American Journal Of Clinical Oncology 2026 PMID: 41972959, DOI: 10.1097/coc.0000000000001329.Peer-Reviewed Original Research
2025
Sinonasal presentations of Rosai–Dorfman disease: a scoping review
Ofori K, Rimmer R. Sinonasal presentations of Rosai–Dorfman disease: a scoping review. The Journal Of Laryngology And Otology 2025, 139: 897-902. PMID: 40734563, PMCID: PMC12558707, DOI: 10.1017/s0022215125103046.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
Get In Touch
Contacts
Email